Healthy Extracts (HYEX) Net Cash Flow Growth (5y) (2020 - 2025)
Healthy Extracts (HYEX) Net Cash Flow Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.23% |
| Sep 30, 2025 | 47.79% |
| Jun 30, 2025 | -33.39% |
| Mar 31, 2025 | 16.03% |
| Dec 31, 2024 | -15.94% |
| Sep 30, 2024 | 53.25% |
| Jun 30, 2024 | -49.78% |
| Mar 31, 2024 | -27.51% |
| Dec 31, 2023 | -42.98% |
| Sep 30, 2023 | -19.37% |
| Jun 30, 2023 | -1.14% |
| Mar 31, 2023 | 87.31% |
| Dec 31, 2022 | -19.66% |
| Sep 30, 2022 | -37.20% |
| Jun 30, 2022 | 102.52% |
| Mar 31, 2022 | -80.71% |
| Dec 31, 2021 | 32.88% |
| Sep 30, 2021 | -41.04% |
| Jun 30, 2021 | 35.99% |
| Mar 31, 2021 | 31.10% |